Literature DB >> 10990174

Mixed connective tissue disease.

R W Hoffman1, E L Greidinger.   

Abstract

A defining feature of mixed connective tissue disease (MCTD) is the presence of antibodies against the U1-ribonucleoprotein (RNP) complex, but other autoantibodies in MCTD have recently been described. Research has also further elucidated the immune responses directed against U1-RNP in humans and in murine models of disease. Hypotheses implicating modified self-antigens and/or infectious agents in the pathogenesis of MCTD have been advanced. Links between the immunologic and clinical phenomena in MCTD are emerging. Longitudinal study of patients with MCTD highlights the impact of pulmonary hypertension on disease outcome.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10990174     DOI： 10.1097/00002281-200009000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN： 1040-8711            Impact factor:   5.006


  12 in total

1.  Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration.

Authors:  Giorgio Tasca; Massimiliano Mirabella; Alfredo Berrettini; Mauro Monforte; Pietro Attilio Tonali; Enzo Ricci
Journal:  Neurol Sci       Date:  2010-10-02       Impact factor: 3.307

2.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

3.  Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.

Authors:  Judit Végh; Györgyike Soós; István Csipõ; Nóra Demeter; Thomas Ben; Balázs Dezsõ; Margit Zeher; Katalin Dévényi; János Gaál; Gyula Szegedi; Edit Bodolay
Journal:  Rheumatol Int       Date:  2005-07-12       Impact factor: 2.631

Review 4.  Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.

Authors:  Britt Nakken; Edit Bodolay; Peter Szodoray
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

5.  Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.

Authors:  Pal Soltesz; Daniel Bereczki; Peter Szodoray; Maria T Magyar; Henrietta Der; Istvan Csipo; Agota Hajas; Gyorgy Paragh; Gyula Szegedi; Edit Bodolay
Journal:  Arthritis Res Ther       Date:  2010-05-06       Impact factor: 5.156

6.  Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.

Authors:  Justin J Leitenberger; Rachael L Cayce; Robert W Haley; Beverley Adams-Huet; Paul R Bergstresser; Heidi T Jacobe
Journal:  Arch Dermatol       Date:  2009-05

7.  Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

Authors:  Claudia Azucena Palafox Sánchez; Minoru Satoh; Edward Kl Chan; Wendy C Carcamo; José Francisco Muñoz Valle; Gerardo Orozco Barocio; Edith Oregon Romero; Rosa Elena Navarro Hernández; Mario Salazar Páramo; Antonio Cabral Castañeda; Mónica Vázquez Del Mercado
Journal:  Arthritis Res Ther       Date:  2009-02-20       Impact factor: 5.156

Review 8.  Selected Aspects in the Pathogenesis of Autoimmune Diseases.

Authors:  György Nagy; Peter C Huszthy; Even Fossum; Yrjö Konttinen; Britt Nakken; Peter Szodoray
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

9.  Silica associated mixed connective tissue disorder in a stone crusher.

Authors:  Arjun Khanna; Jagdish Chander Suri; Animesh Ray; Rahul Kumar Sharma
Journal:  Indian J Occup Environ Med       Date:  2013-05

10.  Cutaneous manifestations of mixed connective tissue disease: study from a tertiary care hospital in eastern India.

Authors:  Sumit Sen; Pradyot Sinhamahapatra; Supriyo Choudhury; Anusree Gangopadhyay; Sanchaita Bala; Geetabali Sircar; Gobinda Chatterjee; Alakendu Ghosh
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.